BSC
CRMD icon

BOLTON SECURITIES CORPORATION’s CorMedix CRMD Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5K Buy
+3,163
New +$23.4K ﹤0.01% 1436

Other funds holding CRMD

Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BOLTON SECURITIES CORPORATION's CRMD Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in CorMedix (CRMD) in Q1 2026: 3,163 shares worth $21.5K. The stake represents ﹤0.01% of the portfolio and ranks #1436 among its holdings.

189 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 3,163 shares of CorMedix worth $21.5K as of Q1 2026.
  • CorMedix was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • CorMedix made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1436 holding.
  • 189 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.